Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

53 ta ish

Ish: Design of competitive inhibitory peptides for 3-hydroxy-3-Methylglutaryl coenzyme A reductase

  1. Isolation and Identification of Peptides from Soy 11S-Globulin with Hypocholesterolemic Activity

    Valeriy V. Pak, Minseon Koo, T. D. Kasymova +1

    MaqolaProtein Hydrolysis and Bioactive PeptidesChemistry of Natural Compounds200514 iqtibos
    ABI

  2. Statin inhibition of HMG-CoA reductase: a 3-dimensional view

    Eva S. Istvan

    Sharh maqola200313 iqtibos
    ABI

  3. Structure—Activity Relationships of the Peptide Ile-Ala-Val-Pro and Its Derivatives Revealed Using the Semi-Empirical AM1 Method

    Valeriy V. Pak, Minseon Koo, N. Lee +2

    Maqola200512 iqtibos
    ABI

  4. Peptide design of a competitive inhibitor for HMG‐CoA reductase based on statin structure

    Valeriy V. Pak, Sung Hee Kim, Minseon Koo +3

    MaqolaComputational Drug Discovery MethodsBiopolymers200610 iqtibos
    ABI

  5. Modeling an active conformation for linear peptides and design of a competitive inhibitor for HMG‐CoA reductase

    Valeriy V. Pak, Minseon Koo, Min Jung Kim +3

    MaqolaOchiq kirishRNA and protein synthesis mechanismsJournal of Molecular Recognition20088 iqtibos
    ABI

  6. Binding effect and design of a competitive inhibitory peptide for HMG-CoA reductase through modeling of an active peptide backbone

    Valeriy V. Pak, Minseon Koo, Min Jung Kim +2

    MaqolaComputational Drug Discovery MethodsBioorganic & Medicinal Chemistry20076 iqtibos
    ABI

  7. Structures of the Peptide Leu-Pro-Tyr-Pro and Its Derivatives and the Nicotinamide Part of NADPH by a Semi-Empirical PM3 Method

    Valeriy V. Pak, Meng-Yu Ku, Na Li +3

    MaqolaEnzyme Structure and FunctionChemistry of Natural Compounds20055 iqtibos
    ABI

  8. Peptide fragmentation as an approach in modeling of an active peptide and designing a competitive inhibitory peptide for HMG-CoA reductase

    Valeriy V. Pak, Minseon Koo, Dae Young Kwon +2

    MaqolaComputational Drug Discovery MethodsBioorganic & Medicinal Chemistry20105 iqtibos
    ABI

  9. Crystal structure of the catalytic portion of human HMG‐CoA reductase: insights into regulation of activity and catalysis

    Eva S. Istvan, Maya Palnitkar, Susan K. Buchanan +1

    MaqolaOchiq kirish20005 iqtibos
    ABI

  10. Syntheses of some α-cyclic tripeptides as potential inhibitors for HMG-CoA Reductase

    Subrata Chakraborty, Shih‐Hung Lin, David Shiuan +1

    Maqola20155 iqtibos
    ABI

  11. Design of a highly potent inhibitory peptide acting as a competitive inhibitor of HMG-CoA reductase

    Valeriy V. Pak, Minseon Koo, Dae Young Kwon +1

    MaqolaComputational Drug Discovery MethodsAmino Acids20124 iqtibos
    ABI

  12. Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase

    Valeriy V. Pak, Dae Yong Kwon, Olim K. Khojimatov +2

    MaqolaComputational Drug Discovery MethodsInternational Journal of Peptide Research and Therapeutics20214 iqtibos
    ABI

  13. In vitro and in silico studies of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitory activity of the cowpea Gln-Asp-Phe peptide

    Mariana Silva, Caio Souza, Biane Oliveira Philadelpho +7

    Maqola20184 iqtibos
    ABI

  14. IAF, QGF, and QDF Peptides Exhibit Cholesterol-Lowering Activity through a Statin-like HMG-CoA Reductase Regulation Mechanism: In Silico and In Vitro Approach

    Mariana Silva, Biane Oliveira Philadelpho, Johnnie Elton Machado dos Santos +9

    Maqola20214 iqtibos
    ABI

  15. Risk of incident diabetes among patients treated with statins: population based study

    A. A. Carter, Tara Gomes, Ximena Camacho +3

    Maqola20133 iqtibos
    ABI

  16. Peptides from cowpea present antioxidant activity, inhibit cholesterol synthesis and its solubilisation into micelles

    Marcelo Rodrigues Marques, Rosana Aparecida Manólio Soares Freitas, Amanda Caroline Corrêa Carlos +3

    Maqola20143 iqtibos
    ABI

  17. IAVPGEVA, IAVPTGVA, and LPYP, three peptides from soy glycinin, modulate cholesterol metabolism in HepG2 cells through the activation of the LDLR-SREBP2 pathway

    Carmen Lammi, Chiara Zanoni, Anna Arnoldi

    Maqola20153 iqtibos
    ABI

  18. Statin use and risk of diabetes mellitus in postmenopausal women

    Niki Katsiki, Maciej Banach

    Maqola20123 iqtibos
    ABI

  19. Lupin protein exerts cholesterol-lowering effects targeting PCSK9: From clinical evidences to elucidation of the in vitro molecular mechanism using HepG2 cells

    Carmen Lammi, Chiara Zanoni, Laura Calabresi +1

    Maqola20163 iqtibos
    ABI

  20. Hypocholesterolemic effect of sericin-derived oligopeptides in high-cholesterol fed rats

    Phakhamon Lapphanichayakool, Manote Sutheerawattananonda, Nanteetip Limpeanchob

    Maqola20163 iqtibos
    ABI

  21. Structure–activity studies of protease activating, lipase inhibiting, bile acid binding and cholesterol-lowering effects of pre-screened cumin seed bioactive peptides

    Hwee-Leng Siow, Sy Bing Choi, Chee‐Yuen Gan

    Maqola20163 iqtibos
    ABI

  22. The Global Burden of Cardiovascular Diseases and Risk Factors

    George A. Mensah, Gregory A. Roth, Valentı́n Fuster

    Tahririyat maqolasi20193 iqtibos
    ABI

  23. Design of competitive inhibitory peptides for HMG-CoA reductase and modeling structural preference for short linear peptides

    Valeriy V. Pak, Olim K. Khojimatov, Aleksandr V. Pak +1

    MaqolaComputational Drug Discovery MethodsJournal of Molecular Structure20223 iqtibos
    ABI

  24. Structure-function properties of hypolipidemic peptides

    Satoshi Nagaoka

    Sharh maqola20182 iqtibos
    ABI

  25. Behavior of three hypocholesterolemic peptides from soy protein in an intestinal model based on differentiated Caco-2 cell

    Gilda Aiello, Simonetta Ferruzza, Giulia Ranaldi +4

    Maqola20182 iqtibos
    ABI